We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Titan Medical Inc | TSX:TMD | Toronto | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.06 | 0.055 | 0.06 | 200 | 12:00:39 |
By Robb M. Stewart
Canadian medical technology company Titan Medical entered a licensing agreement with Johnson & Johnson's Auris Health business covering certain intellectual property.
Titan under the agreement granted Auris a non-exclusive license to a portion of its intellectual property.
The Toronto-based company, which developed a patent portfolio related to the enhancement of robotic-assisted surgery, earlier this year transitioned to an IP licensing company in an effort to generate revenue from licensing existing patents. The move saw Titan terminate research and development and it signed two licensing agreements with two companies in the surgical robotic industry for total upfront payments of $15.5 million.
Write to Robb M. Stewart at robb.stewart@wsj.com
(END) Dow Jones Newswires
August 21, 2023 08:04 ET (12:04 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
1 Year Titan Medical Chart |
1 Month Titan Medical Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions